找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Evidence-based Therapy in Vascular Surgery; E. Sebastian Debus,Reinhart T. Grundmann Textbook 2023Latest edition The Editor(s) (if applica

[复制链接]
楼主: DEIGN
发表于 2025-3-28 17:27:21 | 显示全部楼层
发表于 2025-3-28 22:45:25 | 显示全部楼层
发表于 2025-3-28 23:40:12 | 显示全部楼层
Chronic Limb-Threatening Ischemia (Critical Limb Ischemia),infection and referral to the vascular team is mandatory to improve limb salvage. An endovascular-first strategy is recommended in short lesions. Open surgical procedures may be considered for longer lesions if the surgical risk is acceptable and a suitable autogenous vein is available.
发表于 2025-3-29 03:04:22 | 显示全部楼层
978-3-031-47399-9The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
发表于 2025-3-29 07:37:20 | 显示全部楼层
发表于 2025-3-29 11:58:48 | 显示全部楼层
Energy, Climate and the Environmentr, most rarely, the subclavian artery (arterial TOS, ATOS). The therapy depends on these structures. In a meta-analysis, supraclavicular decompression had the highest success rate for NTOS; the probability of complete freedom from symptoms of 80% or greater was 34% for transaxillary resection of the
发表于 2025-3-29 17:16:47 | 显示全部楼层
发表于 2025-3-29 20:50:44 | 显示全部楼层
https://doi.org/10.1057/9780230355361ecommendations on thoracoabdominal aortic aneurysms (TAAA) are not so clear-cut, as excellent results are achieved with the open approach in highly specialised centres—at least in patients with low or moderate surgical risk. Nevertheless, the technical development of fenestrated and branched stent g
发表于 2025-3-30 01:03:06 | 显示全部楼层
发表于 2025-3-30 06:36:01 | 显示全部楼层
https://doi.org/10.1007/978-3-030-46527-8ressure, renal or cardiovascular outcomes in patients with atherosclerotic renal disease. With few exceptions, medical therapy with antihypertensives, antiplatelet agents and statins is the cornerstone of treatment for patients with renal artery stenosis.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-14 23:26
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表